SpectraWAVE Announces $50M Series B Financing

S3 News
Written By Christine Johnson
 
 
SpectraWAVE
 


SpectraWAVE provides optical and computational insights to improve treatment for coronary artery disease patients. $50M Series B led by Johnson and Johnson, with participation from S3 Ventures, Lumira Ventures, SV Health, and Deerfield.

 
read press release
Christine Johnson
Previous

Prokeep Secures $25M Series A
Next

CereTax Secures $9 Million to Drive Innovation and Expand the Team